Clinical trial
Use of Thalidomide in Patients With Arachnoiditis
NCT00284505 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00284505 |
|---|---|
| Title | Use of Thalidomide in Patients With Arachnoiditis |
| Official title | Prospective Study of the Use of Thalidomide in Patients With Arachnoiditis |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arachnoiditis |
| Intervention type | Drug |
| Interventions | thalidomide |
| Enrollment | 3 |
| Start date | Jul 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Jan 31, 2006 |
| Last update posted | Dec 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: